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FcRI (CD64) Contributes Substantially to
Severity of Arthritis, Hypersensitivity Responses,
and Protection from Bacterial Infection
factors, hampering the definition of its biological role.
Moreover, in vivo, FcRI is occupied by monomeric
IgG2a, reducing its accessibility to newly formed
IgG2a-IC. By using a variety of FcR/ mice, we dem-
onstrate that in the absence of FcRI, the IgG2a-IC-
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type I, II, and III. FcRII/ mice (Takai et al., 1996) show showed little or no binding of monomeric IgG2a, while
wild-type monocytes and Mφ showed extensive bind-an increase in the humoral response, IgG-induced ana-
ing. The residual binding of IgG2a to FcRI-deficientphylaxis, Arthus reaction, and acute glomerulonephritis
Mφmight be due to the existence of as yet unidentifiedand increased susceptibility for the development of anti-
FcRs, the presence of which has recently been reportedbody-mediated autoimmune diseases (Bolland and Ra-
on B cells (Davis et al., 2001).vetch, 2000). Surprisingly, with respect to IgG-depen-
It was previously shown that the expression of humandent immune responses, the phenotype of the FcR/
FcRI on Mφ is increased upon treatment with interferonmouse (Takai et al., 1994), lacking surface expression
 (IFN) (Ting et al., 1999). In the present study, weof both FcRI and FcRIII, strongly resembles the phe-
show that IFN-treated thio-Mφ from FcRII/III/ micenotype of the FcRIII/mouse, leaving the specific con-
display increased binding of monomeric IgG2a com-tribution of the high-affinity IgG receptor, FcRI, to the
pared to untreated Mφ, while FcRI/II/III/ Mφ do notin vivo immune response unclear.
(Figure 1D). This demonstrates that, like in humans, theFcRI preferentially interacts with IgG2a-IC. However,
expression of mouse FcRI is increased by IFN.FcRI shares this capacity with FcRIII and complement
FACS analysis of thio-Mφ from FcRII/III/ mice (ex-factors, making the contribution of FcRI to the in vivo
clusively expressing FcRI), saturated with either mono-IgG2a-IC interactions difficult to define. Moreover, in
meric mouse IgG1, IgG2a, or IgG2b and subsequentlyvivo, FcRI is occupied by monomeric IgG2a, reducing
stained with FITC-conjugated goat anti-mouse IgG (Fig-its accessibility for newly formed IgG2a-IC (Unkeless
ure 2A), revealed that only monomeric IgG2a was boundand Eisen, 1975). Therefore, the widely used passive
by the mouse high-affinity FcRI.forms of hypersensitivity reactions are of restricted
Moreover, FcRI-deficient Mφ showed impaired bind-value to determine the contribution of FcRI to hyper-
ing of IgG2a-IC, while the binding of IC containing othersensitivity. The availability of a newly generated
IgG subclasses was not affected, suggesting that FcRIFcRI/ mouse, together with FcRIII/, FcRI/II/III/,
also preferentially binds IgG2a-IC. Confirming this, Mφand FcRII/III/ mice and the antibody-deficient MT
from the FcRII/III/ mice (exclusively expressingmouse, enabled us to clarify the “hidden” in vivo role
FcRI) effectively bound IgG2a-IC but almost no IC con-of FcRI in a large variety of immune functions and
taining other IgG subclasses (Figure 2B). These dataimmunopathological responses known to be dependent
were confirmed with three different IgG2a antibodies.on FcR chain.
In contrast to a previous report (Gavin et al., 1998),
binding assays performed with sheep red blood cellsResults and Discussion
(SRBC), opsonized with three different IgG3 monoclonal
antibodies, and thio-Mφ from FcRII/III/, FcRI/,Generation of FcRI-Deficient Mice
and wild-type control mice did not show any bindingand General Characteristics
(data not shown). Differences in experimental conditionsA 12 kb targeting construct was generated in which the
could account for this discrepancy. Moreover, it has3 part of the promoter region, the L1 and L2 encoding
been reported that the in vivo protective activity of IgG3
exons, and the 5 part of the ligand binding EC1 domain
is FcR independent and fully complement dependent
encoding exon of the FcRI gene were replaced by the
in cryptococcus infection (Ravetch and Bolland, 2001)
hygromycin resistance gene (Figure 1A). The construct
and candida infection (Han et al., 2001), respectively,
was electroporated into E14 embryonic stem (ES) cells, suggesting that there is no functional interaction be-
the targeted ES clones injected into C57BL/6 blasto- tween FcRI and IgG3. Altogether, these in vitro binding
cysts, and the resulting chimeras bred to Balb/c fe- studies confirmed FcRI as the high-affinity FcR, bind-
males. PCR analysis of tail DNA of agouti pups showed ing monomeric IgG2a. In addition, FcRI preferentially
transmission of the targeted allele (data not shown). bound IgG2a-IC, which can be bound also by the low-
Homozygous FcRI/ mice developed normally and affinity FcRIII.
were fertile. Flow cytometric (FACS) analysis of the main Over the years, the extended analysis of the pheno-
hematopoietic cell populations revealed no gross abnor- type of the FcR  chain-deficient (FcR/) mouse, lack-
malities (data not shown). ing surface expression of both FcRI and FcRIII, re-
The absence of FcRI-specific mRNA in the FcRI/ vealed that FcR-associated FcR are involved in a large
mice was demonstrated by RT-PCR analysis of total variety of IC-dependent immune functions and immuno-
RNA from neutrophils, thioglycolate-elicited peritoneal pathological responses. Because it was unclear to what
macrophages (thio-Mφ), and bone marrow-derived extent FcRI contributes to all these processes, we ana-
macrophages (BMMφ) and bone marrow-derived den- lyzed the different types of immune responses known
dritic cells (BMDC, Figure 1B). Remarkably, no FcRI to be at least partially dependent on FcR. Since we
transcript was detected in neutrophils from wild-type showed that FcRI is the IgG2a receptor of mononuclear
control mice, even after treatment with mouse granulo- cells, our in vitro analysis was restricted to macrophages
cyte colony-stimulating growth factor (G-CSF). We con- and dendritic cells, and the in vivo analysis to model
cluded that, in contrast to humans, mice do not express systems known or believed to be partially or completely
FcRI on neutrophils. dependent on the activity of mononuclear cells. The
The absence of FcRI surface expression was demon- following macrophage functions were analyzed in vitro:
strated by FACS analysis of FcRI/ thio-Mφ, mono- phagocytosis of IC, induction of cytokine production
cytes, and neutrophils saturated with monomeric mouse upon FcR crosslinking by IC, and lysis of tumor cells.
IgG2a and subsequently stained with FITC-conjugated With bone marrow-derived dendritic cells, the contribu-
tion of FcRI to IC-dependent antigen presentation wasgoat anti-mouse IgG2a (Figure 1C). FcRI-deficient cells
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Figure 1. Targeted Disruption of the FcRI Gene
(A) Schematic representation of the wild-type FcRI gene (top), the targeting vector (middle), and the disrupted allele (bottom). The exons
(coding parts in closed, noncoding parts in open boxes) are marked according to the functional domains they encode: L1 and L2, signaling
peptide; Ec1, Ec2, and Ec3, the extracellular immunoglobulin-like domains; T/C, the transmembrane/cytoplasmic tail region. Restriction sites
are: H, HindIII; N, NcoI; B, BamHI; E, EcoRI; C, ClaI; EV, EcoRV; and X, XhoI.
(B) Tissue-specific expression of the FcRI transcript. RT-PCR was performed on total RNA isolated from different cell populations, using
two FcRI specific primer sets, resulting in the amplification of a 1127 bp (lane 1) and a 645 bp (lane 2) fragment (indicated as RI). The HPRT-
specific primers (lane 3) were used as a positive control, resulting in a 164 bp fragment (indicated as HPRT). Tested cells were neutrophils
(a), thio-Mφ (b), and BMMφ (c) and BMDC cultured with three different combinations of mouse cytokines: GM-CSF (d), GM-CSFIL-4 (e),
and GM-CSF  TNF (f). The RI fragments were detected in all wild-type (wt) cell types except neutrophils but in none of the cell types from
FcRI/ mice (RI/).
(C) Flow cytometric analysis of thio-Mφ and circulating granulocytes and monocytes, stained with monomeric mouse IgG2a (thick line) or the
conjugated secondary antibody alone (thin line).
(D) Increased surface expression of FcRI upon IFN treatment of Mφ. Staining was performed with: FITC-labeled anti-IgG2a alone on FcRII/
III/ (dashed line) and FcRI/II/III/ Mφ (solid line) or after saturation with IgG2a and pretreatment with IFN on FcRII/III/ (thick solid line)
and FcRI/II/III/ Mφ (dotted line).
analyzed. In vivo, our studies focused on passive sys- II/III/, and wild-type mice. Mφ from FcRII/III/ mice
showed only substantial phagocytosis of IgG2a-opso-temic anaphylaxis as an example of type I hypersensitiv-
ity and experimental hemolytic anemia as an example of nized SRBC but not of other IgG isotype-IC (Figure 3A),
consistent with the preferential binding of IgG2a-IC bytype II hypersensitivity. Moreover, chronic inflammation
and immunopathological responses in experimental an- FcRI. The phagocytosis of all IgG-IC was abrogated
when FcRI/II/III/ Mφ were used. These results weretigen-induced arthritis and the protection from B. per-
tussis infection were analyzed in the FcRI/ mouse. confirmed with three different mouse IgG2a antibodies
(data not shown) and indicate that the IgG2a-opsonized
particles bound to FcRI are also efficiently phagocy-In Vitro Analysis of the Role of FcRI on Macrophages
tosed by thio-Mφ.To investigate whether FcRI facilitates not only binding
From the difference between efficiency of binding (de-but also phagocytosis of IgG2a-IC, phagocytosis of IgG-
creased, Figure 2B) and phagocytosis (unaffected, Fig-opsonized SRBC was determined using thio-Mφ from
FcRII/III/ mice (exclusively expressing FcRI), FcRI/ ure 3A) of IgG2a-IC by FcRII/III/ thio-Mφ, it can be
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Figure 2. Binding of Mouse IgG1, -2a, and -2b to FcRI
(A) Flow cytometric analysis of thio-Mφ, originating from FcRII/III/ mice, stained with monomeric mouse IgG1, -2a, and -2b anti-TNP class-
switch variants (thick line) or the secondary antibody alone (thin line).
(B) Binding of TNP-labeled SRBC opsonized with IgG1 (small dots), IgG2a (large dots), or IgG2b (black fill) anti-TNP class-switch variants or
unopsonized (white fill) to wild-type (wt), FcRI/, FcRII/III/, and FcRI/II/III/ thio-Mφ. Data are expressed as the ratio between the
number of SRBC bound and the number (100) of counted Mφ. One representative experiment out of three performed is shown.
concluded that, given sufficient time, FcRI fully com- tumor cells by Mφ. Since ADCC with murine blood is
known to be more effective after stimulation with mousepensates for the absence of FcRIII in phagocytosis.
It has been reported that ligation of FcR on Mφ can G-CSF in vivo, neutrophils are considered to be the
effectors responsible for inducing lysis of IgG-coatedlead to a reversal of Mφ proinflammatory responses to
bacterial stimuli by inducing production of interleukin- tumor target cells (Valerius et al., 1993). To assess the
role of FcRI in this process, we used a standard short-10 (IL-10), with a subsequent inhibition of interleukin-12
(IL-12) production. Moreover, comparison of Mφ from term chromium release assay with whole blood from
FcRI/ mice as effector and SK-BR-3 tumor cells asFcRII/, FcRIII/, and FcR/ mice suggested a
dominant role for FcRI in this process (Sutterwala et target. We demonstrated that the reported IgG2a-medi-
ated cytotoxicity is FcRI independent in this assayal., 1998). Here, we show that production of IL-10 by
FcRI/ and FcRIII/ Mφ, upon treatment with lipo- (data not shown), confirming a dominant role for neutro-
phils (which lack FcRI expression, Figure 1B) in thispolysaccharide (LPS) and rabbit IgG-opsonized SRBC
(E-IgG), which can interact with all three mouse FcR, process.
was comparable to that found with wild-type Mφ (Figure
3B). Since the absence of both FcRI and FcRIII abro- MHC Class I-Restricted Antigen Presentation
by Bone Marrow-Derived Dendritic Cellsgated the production of IL-10 by FcR/ Mφ, we con-
cluded that both activating FcRs contribute equally to Presentation of IgG-complexed antigens by dendritic
cells is more efficient than presentation of soluble anti-the FcR-mediated reversal of proinflammatory re-
sponses by Mφ. Furthermore, these results suggest gens (Sallusto and Lanzavecchia, 1994). We have pre-
viously shown that the enhanced MHC class I-restrictedthat, under these conditions, the FcRI- and FcRIII-
initiated signal transduction pathways are similar. presentation of peptides from exogenous IgG-com-
plexed antigens by murine BMDC requires the presenceMφ are known to exhibit antibody-dependent cell-
mediated cytotoxicity (ADCC) to kill tumor cells (Ely et of FcR (Regnault et al., 1999). Here, we assess the
individual contribution of FcRI (and FcRIII) to this pro-al., 1996). More recently, FcR were reported to be impor-
tant for the in vitro and in vivo antitumor activity of cess by comparing BMDC from FcRI/, FcRIII/,
FcR/, and wild-type mice in their efficiency of pre-antibodies (Honeychurch et al., 2000; Keler et al., 1997).
Therefore, we assessed the role of FcRI in the IgG2a- senting the chicken ovalbumin (OVA) peptide 257–264
to the OVA-specific CD8 T cell hybridoma B3Z, uponmediated cytotoxicity by using Mφ from wild-type and
FcRI/ mice as effector and the A431 human epider- exposure to the peptide, soluble OVA, or OVA/ rabbit
IgG anti-OVA IC (OVA-IC) (Figure 4). The enhanced MHCmoid carcinoma cell line (Figure 3C) or the SK-BR3 hu-
man breast carcinoma (data not shown) as targets. After class I-restricted presentation of the OVA peptide from
OVA-IC was partially reduced in the absence of FcRIa 48 hr incubation of the effector cells with the tumor
cells in the presence of increasing concentrations of or FcRIII and was completely abrogated when both
receptors were absent (FcR/), while all BMDC weretumor-specific IgG2a antibody, we found that the killing
of the target cells by FcRI-deficient Mφ was markedly able to present with the same efficiency the soluble
peptide and protein. Therefore, we concluded that bothimpaired compared to the killing by wild-type Mφ. These
results were independent of the tumor cell line used FcRI and FcRIII are responsible for the enhanced
MHC class I-restricted presentation of IC-derived pep-(data not shown), and they show that FcRI, together
with FcRIII, is involved in the IgG2a-mediated killing of tides by BMDC, in vitro.
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Figure 3. Analysis of the FcRI Function on Macrophages In Vitro
(A) Phagocytosis of TNP-labeled SRBC, opsonized with IgG1 (small dots), IgG2a (large dots), or IgG2b (black fill) anti-TNP class-switch variants
or unopsonized (white fill) by wild-type (wt), FcRII/III/, and FcRI/II/III/ thio-Mφ. The average number of SRBC ingested by one macrophage
is presented. The mean of triplicate samples from a representative experiment out of two performed is shown.
(B) Production of IL-10 by BMMφ. The production of IL-10 by wild-type, FcRI/, FcRIII/, and FcR/ BMMφ, stimulated with LPS, rabbit
IgG/SRBC immune complexes (E-IgG), or the combination of LPS and E-IgG, is measured. Untreated macrophages (MED) were used as
negative control. The mean IL-10 titers of triplicate samples of one representative experiment out of three performed are presented.
(C) IgG2a-dependent killing of tumor cells by macrophages. Wild-type (wt) and FcRI/ thio-Mφ were incubated with the EGF-R positive
A431 tumor cell line, in the absence or presence of 1, 3, or 5 g/ml of m425 antibody (mouse IgG2a anti EGF-R). After 48 hr, the whole
population of cells was stained with F4/80 (monocyte/macrophage specific) and Ab-3 (mouse IgG1 anti-EGF-R) antibodies and analyzed by
flow cytometry. The percentage of viable A431 tumor cells left in culture is shown. One representative experiment out of three performed is
presented.
Hypersensitivity Reponses (AIHA), when the molecularly engineered low-affinity
4C8 mouse IgG2a anti-RBC antibody is used (Fossati-Type II: Experimental Autoimmune Hemolytic Anemia
We reported previously that FcRIII has a prominent role Jimack et al., 2000), whereas FcRI becomes involved
only when high amounts of this antibody are present.in the pathogenesis of autoimmune hemolytic anemia
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Figure 4. MHC Class I-Restricted Presentation of Antigen by Bone Marrow-Derived Dendritic Cells
Bone marrow-derived dendritic cells (BMDC) from different mice were incubated with the indicated concentrations of soluble OVA (protein),
OVA-IC (with 50 g/ml rabbit IgG anti-OVA), and the OVA 257-264 peptide (peptide) for 24 hr in the presence of B3Z T cells. The T cell
response was quantified as described in Experimental Procedures. Mean  SEM values of one representative experiment in duplicate out of
three performed is shown.
Here, we determine the role of FcRI (and FcRIII) in the upon challenge in systemic anaphylaxis, macrophages
activated via FcRI release vasodilatatory mediators,development of AIHA, induced by a single i.p. injection
of 100 g high-affinity 34-3C (mouse IgG2a anti-RBC) possibly platelet-activating factor (PAF), which contrib-
ute significantly to hypotension and mortality. Presum-antibody in wild-type, FcRI/, FcRIII/, and FcR/
mice (Figure 5A). FcRIII/ and FcRI/ mice showed ably, in vivo, IgG2a of a particular specificity needs to
compete for the high-affinity FcRI with a constitutiveboth partial protection from the AIHA-inducing antibody
compared to wild-type controls, while FcR/ mice abundant and extensive repertoire of IgG2a antibodies.
Indeed, in the IgG-deficient MT mice, a 4-fold lowerwere resistant. All mice showed normal hematocrit lev-
els (around 50%) on day 0. These results provide direct dose of IgG2a (100 g) was sufficient to induce marked
delayed hypotension (Figure 5C) and high mortality (3/3)evidence that FcRI is involved in the pathogenesis of
AIHA. Its role became more evident when naturally oc- after challenge compared to wild-type controls (mortal-
ity 0/3). A similar dose of IgG1 antibodies, which inter-curring high-affinity antibodies against RBC were used.
Type I: Systemic Anaphylaxis acts preferentially with FcRIII, did not show an addi-
tional effect in the MT mice compared to wild-typeIt has been previously demonstrated that many physio-
logical characteristics of active systemic anaphylaxis in controls. From these experiments, we conclude that
FcRI on macrophages contributes substantially tomice, including mortality and tachycardia, can be mim-
icked by passive IgE- or IgG1-dependent anaphylaxis. IgG2a-induced systemic anaphylaxis.
Furthermore, these models were largely FcR chain de-
pendent (Miyajima et al., 1997). Although IgE and IgG1 Experimental Antigen-Induced Arthritis
It was previously demonstrated that in experimental an-degranulate mast cells via FcRI and FcRIII, respec-
tively, it is clear that active anaphylactic responses per- tigen-induced arthritis (AIA) elicited in knee joints,
FcR/ mice develop much less joint swelling com-sist in mast cell-deficient mice (Martin et al., 1993; Miya-
jima et al., 1997). We found that passive sensitization pared to wild-type mice, while exudate and infiltrate
were similar. Remarkably, severe cartilage destructionwith IgG2a (400 g) results in severe delayed hypoten-
sion (Figure 5B) and high mortality (5/6) after challenge. was absent (van Lent et al., 2000). In the present study,
we examined the individual role of FcRI (and FcRIII)The delayed hypotensive response in IgG2a-dependent
anaphylaxis was strongly inhibited in FcRI/ mice and in inflammation and functional cartilage damage in knee
joints of animals with AIA, using FcRI/, FcRIII/,partially inhibited in FcRIII/ mice (Figure 5B). Further-
more, mortality was also decreased in both FcRI/ and and the proper wild-type control mice. Three weeks after
immunization with methylated BSA (mBSA), both spe-FcRIII/ mice after challenge. Interestingly, antigen
challenge resulted in an acute hypotensive effect in cific T cell responses and total IgG, IgG1, IgG2a, and
IgG2b titers against mBSA were the same in all groupsFcRIII/ mice compared to wild-type control. Martin et
al. (1993) also described an additional acute hypotensive (data not shown). After challenge, joint swelling, as mea-
sured by 99mTc uptake at day 1, 3, and 7, was similar ineffect in mast cell-deficient mice compared to control
in a murine model of active anaphylaxis. We suggest that all groups as was exudate and infiltrate in the knee
FcRI in Inflammation and Bacterial Infections
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Figure 5. IgG2a-Mediated Hypersensitivity Responses
(A) Autoimmune hemolytic anemia. Day 4 hematocrit levels (Ht) of wild-type (wt), FcRI/, FcRIII/, and FcR/ mice are depicted. Each
mouse is individually represented, and the mean Ht values of each group are indicated. One representative experiment out of three performed
is shown.
(B) The systemic anaphylaxis response after passive sensitization with IgG2a (400 g/mouse) is modified and attenuated in the FcRI/ and
FcRIII/ mouse. The change in mean arterial pressure (MAP) after challenge with DNP-HSA (1 mg/mouse) is depicted as mean  SEM (n 	
5–6). *** P 
 0.001 and * P 
 0.05 compared to wild-type.
(C) The systemic anaphylaxis response after passive sensitization with IgG2a but not IgG1 is enhanced in IgG-deficient MT mice compared
to wild-type mice. The sustained decrease in mean arterial pressure (MAP) at 15 min after challenge with DNP-HSA (1 mg/mouse) is depicted
as mean  SEM (n 	 3). ** P 
 0.01 compared to wild-type, which received 100 g IgG2a. n.d. 	 not determined, since mortality is 100%
already at 100 g IgG2a.
joint injected (data not shown). Aggrecan breakdown whereas FcRI is the dominant FcR involved in severe
cartilage destruction.in cartilage, caused by metalloproteinases (MMP) and
related to severe irreversible cartilage erosion, was fur-
ther studied by immunolocalization of MMP-mediated Bordetella pertussis Infection
B. pertussis is the pathogen that causes whoopingformation of neo-epitopes (VDIPEN). MMP-induced
neo-epitope formation, determined in the cartilage of cough in humans and is responsible for a high mortality
rate in infants. In the current mouse models, B. pertussislateral tibia, was largely inhibited but not absent in
FcRI/ mice and unchanged in FcRIII/ mice com- infection leads to colonization of the trachea and lungs
without causing mortality. In wild-type mice, coloniza-pared to wild-type control mice (Figure 6). The amount
of VDIPEN was measured by determining the area of tion of the lung increases with the administered dose
of live B. pertussis, reaching a maximum after 3 days,VDIPEN staining, using automated image analysis (van
Lent et al., 2000). The results for the lateral tibia, ex- while the infection is almost completely cleared after 21
days (Mills, 2001). Antibodies specific for B. pertussispressed as mean surface area  SEM (m2 ), were as
follows: Balb/c/Ola129 control, 669  213; FcRI KO, have been documented to contribute to protection
against whooping cough (Cherry et al., 1998), and pas-85  119; C57Bl/6 control, 844  61; and FcRIII KO,
402  329 (n 	 10, p 
 0.05 for FcRI KO relative to sive immunization experiments in mice suggested a role
for both FcRI and FcRIII in protection (S.M. Hellwig etcontrol as assessed using the Wilcoxon test). These
results suggest that during experimental AIA, FcRI and al., submitted). Here, we show that, upon nasal infection
with live B. pertussis particles, the clearance of theFcRIII act in concert in acute and chronic inflammation,
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Figure 6. Cartilage Destruction in Antigen-Induced Arthritis
Deparaffinized total knee joint sections, showing the tibia (prepared as described in Experimental Procedures) of affected Balb/c/Ola129 (A)
or C57Bl/6 (C) wild-type, FcRI/(B), and FcRIII/ (D) and nonarthritic control (E) mice were stained for VDIPEN. Arrowheads indicate ruffling
(erosion) of the cartilage surface. The original magnification of the photographs is 200. Ten mice per group were investigated.
pathogen is markedly impaired in the FcRI/ mice 7). Specific IgG1 and IgG2a titers against B. pertussis,
measured 21 days after infection, showed no differencecompared to the clearance in their wild-type controls,
as measured in the lungs 21 days after infection (Figure between FcRI/ mice and their wild-type controls
Figure 7. B. pertussis Infection
Colonization of the lungs of wild-type
(squares) and FcRI/ mice (triangles), 21
days after nasal infection with 107 live B. per-
tussis particles. The number of colony-form-
ing units (CFU) of the pathogen present in the
lungs of infected animals is presented in a
logarithmic scale. Each mouse is individually
represented. Statistisical analysis was per-
formed using the Student’s t test (p 	 0.005).
One representative experiment out of three
performed is presented.
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3.5 C57Bl/6 embryos, two out of three independent clones, bearing(data not shown), even though a nonsignificant tendency
a targeted FcRI allele as identified by Southern blot, gave rise tofor increased B. pertussis-specific IgG2a titers was de-
male chimeras that were bred to Balb/c females. Tail DNA from thetected in the sera from the FcRI/ mice. These results
offspring was analyzed by PCR for the presence of the mutated
suggest that FcRI has a prominent role in protection allele. The following primers were used: 5CCTCACACCATAAAGT
against colonization by B. pertussis in lungs. GACATTT3 (EC1), 5GGAAGTGGGTGAGTGACCTCT3 (L2), and
5TCGCCGATAGTGGAAACCGAC3 (hygro), giving rise to a 1.05 kbp
(wild-type allele) and a 550 bp (mutated allele) band. HeterozygousConcluding Remarks
offspring carrying the mutation were backcrossed for two genera-In the present study, we identified the mouse FcRI
tions with Balb/c animals and subsequently intercrossed. Homozy-as an IgG receptor preferentially mediating IgG2a-IC-
gous FcRI/ and wild-type littermates were selected to establish
induced effector functions of mononuclear cells but not two independent FcRI/ mouse strains with indistinguishable phe-
neutrophils. FcRI is always expressed together with notype and the proper (Balb/c/Ola129) wild-type control strain.
FcRIII, while FcRIII is the only activating FcR on
neutrophils, NK-, and mast cells. IgG1-IC bind with Mice
C57Bl/6 and Balb/c inbred mice were purchased from Charles Riverstrong preference to FcRIII (Hazenbos et al., 1998).
(Iffa Credo, Lyon, France). FcRIII/ mice were backcrossed for 12However, the main ligand of FcRI, IgG2a, interacts in
generations on C57/B6 background. FcRII/III/ animals and theircomplexed form efficiently also with FcRIII and com-
wild-type littermates were generated by breeding FcRII/ miceplement factors. The only remaining unique feature of
(Takai et al., 1996) with FcRIII/ mice and selecting for homozy-
FcRI is its ability to bind monomeric IgG2a. A direct gous FcRII/III/ and FcRII/III/ offspring (Ola129/C57Bl/6).
consequence of this feature is that high IgG2a titers of FcRI/II/III/ mice and their wild-type littermates were generated
by crossing FcRI/ with FcRII/III/ mice and selecting for FcRI/a particular specificity are required to compete with the
II/III/ and FcRI/II/III/ littermates (Balb/c/Ola129/C57Bl/6).abundant and extensive repertoire of IgG2a antibodies,
C57Bl/6 FcR/ mice were generated by Dr. T. Saito (Park et al.,that occupy FcRI permanently in vivo. This is exempli-
1995) and maintained in our animal facility. MT mice, backcrossedfied by the fact thatMT mice, lacking immunoglobulins,
eight generations on C57Bl/6, were purchased from the Jackson
have increased sensitivity to systemic anaphylaxis. The Laboratory. Two- to four-month-old homozygous mutants and the
in vitro results we presented are in agreement with these proper wild-type controls were used in all experiments. All animals
were maintained under specific pathogen-free conditions in the Ani-characteristics of FcRI. In all cases, the data strongly
mal Facility of the Leiden University Medical Center (LUMC), Thesuggest that both receptors, FcRI and FcRIII, contrib-
Netherlands.ute substantially to the IgG2a-IC-dependent FcR-
mediated processes tested. However, the in vivo experi-
Cells and RT-PCRments revealed surprisingly strong differences between
Thio-Mφ were obtained by washing with 5 ml cold RPMI 1640 me-FcRI/ and wild-type controls in models of arthritis,
dium (GIBCO-BRL) containing 10% FCS and antibiotics (complete
systemic anaphylaxis, and protection from B. pertussis RPMI medium), the peritoneal cavity of mice injected i.p. 4 days
infection. These results suggest that, under particular before with 1 ml of 4% thioglycolate medium (Becton Dickinson,
Mountain View, CA). BMMφ were established as described pre-in vivo conditions, FcRIII and complement are not able
viously (Sutterwala et al., 1997). Dendritic cells were obtained fromto compensate for the loss of FcRI in the FcRI/
femur bone marrow, cultured for 7 days in complete RPMI mediummouse. One of the explanations could be that, like in
in the presence of 50 ng/ml recombinant murine GM-CSF alonehumans, FcRI expression is controlled by certain cyto-
(GM-CSF, Immunex), GM-CSF and 10 ng/ml recombinant murine
kines, as we have shown in the present study, using IL-4 (IL-4, R&D Systems), or GM-CSF and 25 ng/ml recombinant
IFN-treated macrophages (Figure 1D). In addition, the murine TNF (TNF, Hycult). Nonadherent and loosely adherent
cells were replated on day 1 on new culture plates, and the mediumenhancing effect of a viral infection on the sensitivity
and cytokines were refreshed on day 4. Nonadherent and looselyfor IgG2a-induced experimental hemolytic anemia sug-
adherent cells were harvested on day 7 and used for isolation ofgests a direct effect of virus-induced cytokines on the
total RNA. Neutrophils were isolated from whole blood of mice thatexpression level and subsequent biological activity of
received a single subcutaneous injection of 15 g polyethylene-
FcRI (Meite et al., 2000). glycol granulocyte colony-stimulating growth factor (PEGG-CSF,
Altogether, our data suggest that, while FcRIII is the kindly provided by Dr. J. Andresen, Amgen, Thousand Oaks, CA) 3
days before, by staining for 10 min at room temperature with PE-only functional activatory FcR on neutrophils, mast
labeled Gr-1 antibody (Pharmingen) directed against Ly1.2 surfacecells, and NK cells, FcRI is dominant over FcRIII on
marker present on neutrophils and, at low levels, on monocytes,mononuclear cells in mice. In humans, where FcRI is
followed by sorting using the FACStar sorter (Becton Dickinson).also expressed on neutrophils, its role is likely to be
Cells which were both positive for the Gr-1 surface marker and
even more prominent, and therefore FcRI polymor- presented the forward/side scatter characteristics of granulocytes
phisms may have a major impact on the outcome of were gated. Less than 6% of the sorted cells were monocytes.
Total RNA was isolated from the above-mentioned cells using theinflammation, hypersensitivity, and bacterial infection.
RNAgents Total RNA Isolation System kit (Quiagen). One microgram
total RNA was reverse transcribed by using cloned AMV reverseExperimental Procedures
transcriptase (Promega), and the FcRI-specific cDNA was ampli-
fied using the following two sets of primers: 5AAGTGGTTAATGCGeneration of the FcRI-Deficient Mice
Within a genomic HindIII/EcoRI restriction fragment of 12 kbp that CACCAAGG3 (1RIs) and 5TGTGCCCCAGTACTGTCACT3 (1RIas)
resulting in a 1127 bp fragment and 5GTGCAGTTGCAAATCCAcontains a large 7.8 kb 5 noncoding promoter region, the L1 and
L2 encoding exons, and the EC1 exon and 2.7 kb of the adjacent CAATG3 (2RIs) and 5CATAGAGAACCGTGTTCAACG3 (2RIas) re-
sulting in a 645 bp fragment. HPRT primers were used as positiveintron of the FcRI gene, a 3 kbp BamHI-NcoI fragment, containing
the 3 part of the promoter region, the L1 and L2 encoding exons, control, resulting in a 164 bp fragment (Peterson et al., 1994). After
an initial denaturation step of 5 min at 95C, 35 cycles were per-and the 5 part of the EC1 encoding exon, was replaced with the
PGK-hygror cassette. Transfection of the targeting vector and sub- formed with the following steps: denaturation 1 min 95C, annealing
1 min 60C, and elongation 2 min 72C, followed by one elongationsequent selection and screening of the recombinant ES cells were
performed using standard procedures. After microinjection into day step of 10 min at 72C.
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Monomeric IgG Binding washes and a subsequent staining step of 30 min on ice, with 10
g/ml FITC-labeled goat F(ab)2 anti mouse IgG1 and PE-labeled1–5  105 thio-Mφ or 25 l whole blood were washed once with
PBS/1%BSA/0.01% sodium azide (FACS buffer), then the cell- streptavidine. The percentage of EGF-R positive cells from the total
number of cells in each sample was assessed, using a FACScanbound IgG was eluted by two serial 30 s incubations at room temper-
ature with acid elution buffer (20 mM glycine, 1 mg/ml BSA, 130 and CellQuest software (Becton Dickinson).
mM NaCl, and 2 mM CaCl2 [pH 2.5]), separated by one wash with
FACS buffer. Cells were washed twice with FACS buffer and incu- Antigen Presentation Assay
bated 30 min on ice (thio-Mφ) or 10 min at room temperature (whole BMDC were cultured from bone marrow cells for a minimum of 14
blood), with 25 g/ml purified mouse IgG1, -2a, or -2b anti-TNP days in IMDM medium (Sigma) containing 10% FCS (Abcys), 100 IU/
class-switch monoclonal antibodies, in combination with 10 g/ml ml penicillin, 100 mg/ml streptomycin (Seromed), 2 mM L-glutamine,
biotin-labeled F4/80 against monocytes/macrophages (Serotec) or and 50 mM 2-Me and supplemented with 30% conditioned medium
PE-labeled Gr-1, followed, when necessary, by a secondary staining from mouse GM-CSF-producing J558 cells (kindly provided by Dr.
with 10 g/ml FITC-labeled goat F(ab)2 anti murine IgG1, -2a, and D. Gray). The MHC class I-restricted presentation of OVA epitope
-2b (SBA) together with PE-conjugated streptavidine (Becton Dick- 257-264 (H-2Kb specific) by BMDC was assessed as previously de-
inson). When specified, thio-Mφ were adhered to plastic plates in scribed (Regnault et al., 1999). In brief, 5 104 BMDC were exposed
a concentration of 1  105 cells/well in RPMI containing 1% FCS to the specified concentrations of OVA peptide 257-264, OVA protein
and stimulated overnight with 100 ng recombinant rat IFN (kindly alone (Worthington), or OVA-IC, formed by preincubating increasing
provided by Dr. P. van de Meide, U-CyTech, Utrecht, The Nether- concentrations of OVA with 50 g/ml rabbit IgG, purified from whole
lands). The next day, they were detached using 5 mM EDTA in rabbit serum (Sigma), in the presence of 5  104 cells of the T cell
PBS and stained. Analysis was performed using a FACScan and hybridoma B3Z (Sanderson and Shastri, 1994). B3Z is specific for
CellQuest software (Becton Dickinson). the Kb immunodominant 257-264 OVA epitope. After 24 hr, cells
were washed and a colorimetric assay, using CPRG (Calbiochem)
as a substrate, was used to detect LacZ activity in B3Z lysates.Binding and Phagocytosis of IgG-Opsonized SRBC by Thio-Mφ
Sheep red blood cells (SRBC) were washed five times with ice-cold
PBS by centrifugation at 1600 rpm for 5 min, and TNP-conjugated Experimental Autoimmune Hemolytic Anemia
by incubating 67 l washed SRBC pellet with 1 ml 0.3 M cacodylate Autoimmune hemolytic anemia was induced by a single i.p. injection
buffer (pH 6.9) and 72l 5% TNBS solution (Sigma) at room tempera- on day 0 of 100 g purified 34-3C (high-affinity mouse IgG2a anti-
ture for 15–20 min. After being washed ten times with cold PBS, 6.5 mouse red blood cells) into the specified mice. Blood samples were
l pellet of SRBC-TNP was opsonized with 5 g/ml IgG anti-TNP collected in heparinized microhematocrit tubes at the indicated time
class-switch variants or 1M-F10 antibody (IgG3 anti TNP, a kind gift points, and the hematocrit levels (Ht) were measured as described
of Dr. B. Heyman, University of Uppsala, Sweden), by incubating (Shibata et al., 1990)
for 30 min at 37C. Next, the opsonized SRBC were washed three
times with medium, and a 0.3% dilution (v/v) in complete RPMI Passive Systemic Anaphylaxis
medium was used for the assay. For binding, 2 g/ml cytochalasin Mouse monoclonal class-switch variant IgG anti-TNP antibodies
D (Sigma) was added to the SRBC. In some cases, nonconjugated (100–400 g, in sterile, pyrogen-free 0.9% NaCl) were adminis-
SRBC were opsonized with 5 g/ml 10-3 antibody (IgG3 anti SRBC, tered i.v. by tail vein in volumes of 0.1–0.2 ml/mouse. Three to five
kindly provided by Dr. B. Heyman). Thio-Mφ were washed twice hours after passive sensitization, mice were anaesthetized and the
with PBS, red blood cells were lysed, and the remaining cells were carotid artery was cannulated for the physiological measurement
washed twice with PBS, resuspended in RPMI medium, and plated of mean arterial pressure (MAP). Subsequently, mice were chal-
in 24-well plates at a concentration of 1  105 cells/well. They were lenged by an i.v. injection of 100 l of sterile, pyrogen-free 0.9%
left to adhere to plastic during a 3 hr incubation at 37C. Nonadherent NaCl containing 1.0 mg of DNP-HSA (Sigma). Statistical analysis
cells were washed away with PBS, and 250 l aliquots of opsonized was performed using the Bonferroni’s multiple comparison test.
SRBC were added to each well. For binding, this was preceded by
an additional incubation step with 250 l medium containing 2 g/ Experimental Antigen-Induced Arthritis
ml cytochalasin D, for 30 min at 37C. The plates were incubated Mice were injected with 100 g methylated BSA (mBSA, Sigma)
for 30 min at 37C. For binding, nonbound erythrocytes were washed emulsified in 100 l complete Freunds adjuvant (CFA), in both flanks
away with PBS; for phagocytosis, extra cellular erythrocytes were and in the footpath of the forelegs, simultaneously with an i.p. injec-
lysed by hypotonic shock. Cells were fixed with 2% paraformalde- tion of heat-killed B. pertussis (RIVM, Bilthoven, The Netherlands).
hyde for 30 min room temperature, and the number of bound or Two subcutaneous booster injections followed in the neck region,
ingested erythrocytes was determined by light microscopy. 1 week after immunization, with 50 g mBSA/CFA. Chronic arthritis
was induced 2 weeks after the booster by an intraarticular injection
Cytokine Production by Macrophages of 60 g mBSA in 6 l physiological salt into the right knee joint.
The production of IL-10 by BMMφ in response to LPS stimulation For immunohistochemical analysis, sections were deparaffinized,
and FcR ligation was assessed as previously described (Sutterwala rehydrated, and digested with chondroitinase ABC (Sigma, 0.25 U/
et al., 1998). In brief, BMMφ monolayers were stimulated with 100 ml, 0.1 M Tris-HCL [pH 8.0]) for 1 hr at 37C to remove chondroitine
ng/ml LPS (Escherichia coli 0127:B8, Sigma) or SRBC, opsonized sulfate from the proteoglycans. Sections were treated with 1% H2O2
with rabbit IgG anti SRBC (Organon Teknika-Cappel) at nonaggluti- in methanol for 20 min and subsequently 5 min with 0.1% (v/v) triton
nating titers for 40 min at room temperature, or both. The SRBC X-100 in PBS. After incubation with 1.5% (v/v) normal goat serum for
were added to the macrophage layers at a ratio of 20:1. After 24 hr, 20 min, sections were incubated with the extensively characterized
the cytokine titers in the supernatants were measured by ELISA. (Singer et al., 1995) affinity-purified rabbit anti-VDIPEN IgG (kind gifts
from Irwin Singer and Ellen Bayne, Merck Research Laboratories,
Rahway, NJ) overnight at 4C. In addition, sections were incubatedAntibody-Dependent Killing of Tumor Cells
with biotinylated goat anti rabbit IgG and binding detected usingThio-Mφ, at a concentration of 6  105 /well, were plated in RPMI
avidine-peroxidase staining (Elite kit, Vector Labs, Inc., Burlingham).1640 medium in 24-well plates and left to adhere overnight. Next,
Development of the peroxidase product was performed using nickelnonadherent cells were washed away, and 1 105 A431 (epidermoid
enhancement, and counterstaining was done with orange G (2%)carcinoma, [Giard et al., 1973]) or SK-BR3 (human breast carcinoma,
for 5 min. Statistical analysis was performed using the Wilcoxon[Keler et al., 1997]) tumor cells were added to each well, in the
test.presence of the specified concentrations of the 425 antibody (mouse
IgG2a anti-EGF-R, Merck). Two days later, the cells were trypsinized,
washed twice with PBS/1% BSA/0.01% sodium azide, and incu- Colonization and Anti-B. pertussis Titers in Mice
following Infection with the Pathogenbated for 30 min on ice with biotin-labeled F4/80 and the Ab-3
antibody (mouse IgG1 anti-EGF-R, Oncogene Research Products), Culturing of the B. pertussis strain B213 and intranasal infection of
mice were performed as previously described (Hellwig et al., 1999).both at a concentration of 10 g/ml. This was followed by two
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In brief, mice were anaesthetized with ether, and 20 l of inoculum directed bispecific antibodies in B-cell lymphoma. Blood 96, 3544–
3552.(containing 1  107 B. pertussis) was placed on the top of each
nostril. The mice were killed 21 days after infection by intramuscular Keler, T., Graziano, R.F., Mandal, A., Wallace, P.K., Fisher, J., Guyre,
injection of an overdose of Nembutal (Sanofi). Lungs were excised, P.M., Fanger, M.W., and Deo, Y.M. (1997). Bispecific antibody-
homogenized using a blender in Verwey medium, and viable bacteria dependent cellular cytotoxicity of HER2/neu-overexpressing tumor
determined by plating serial dilutions on Bordet Gengou agar plates cells by FcRI-expressing effector cells. Cancer Res. 57, 4008–4014.
supplemented with 30 g/ml streptomycin. IgG titers against B.
Martin, T.R., Ando, A., Takeishi, T., Katona, I.M., Drazen, J.M., and
pertussis were determined by Elisa as described (Nagel et al., 1985).
Galli, S.J. (1993). Mast cells contribute to the changes in heart rate,
but not hypotension or death, associated with active anaphylaxis
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